JD Health Schedules 29 June 2026 AGM; Seeks Renewal of 20% Issue Mandate, 10% Buy-back Authority and Board Re-elections

Bulletin Express
Jun 05

JD Health International Inc. will hold its Annual General Meeting on 29 June 2026 at 10:00 a.m. at its Yizhuang headquarters in Beijing. Key resolutions include:

1. Capital Mandates • A new general mandate authorising directors to allot and issue up to 20% of the issued share capital, equivalent to 639.83 million shares based on the 3.20 billion shares outstanding (excluding treasury and pending-cancellation shares) as at 26 May 2026. • A repurchase mandate permitting buy-backs of up to 10% of shares in issue, or 319.92 million shares. • An extension mandate allowing the issue limit to be increased by any shares repurchased under the buy-back authority. If approved, the mandates will remain effective until the next AGM or earlier revocation.

2. Board Composition Shareholders will vote on the re-election of: • Dong Cao, Chief Executive Officer (executive director). • Richard Qiangdong Liu, Chairman (non-executive director). • Ling Li, Chair of the Remuneration Committee (independent non-executive director).

3. Auditor Deloitte Touche Tohmatsu is nominated for re-appointment as external auditor for 2026. The audit fee is estimated at RMB 7.00 million–8.00 million, exclusive of out-of-pocket expenses.

4. Administrative Details • Share register closure: 24–29 June 2026 (both days inclusive). • Proxy forms must reach Computershare Hong Kong Investor Services by 10:00 a.m. on 27 June 2026. • All AGM voting will be conducted by poll.

5. Recent Buy-backs Between 15–26 May 2026 the company repurchased 11.61 million shares on-market at prices ranging from HK$ 38.44 to HK$ 45.30.

6. Major Shareholder Position As of the latest practicable date, Chairman Richard Qiangdong Liu held or controlled approximately 70.04% of issued shares. Full utilisation of the repurchase mandate would raise his aggregate holding to about 77.79%, still below the level that would trigger a mandatory offer under Hong Kong’s Takeovers Code.

No shareholder is required to abstain from voting on the proposed resolutions. The board recommends approval of all items.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10